View printer-friendly version << Back
MEDNAX Announces Acquisition of Three Practices in Sacramento, Calif.

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Mar. 29, 2012-- MEDNAX, Inc., (NYSE: MD) today announced the acquisition of three practices formerly part of Children’s Specialists Medical Group of Sacramento, Inc. (CSMGS) based in Sacramento, Calif.

The acquisition of these three subspecialty practices within CSMGS includes neonatology, perinatology and pediatric critical care practices which brings 9 neonatologists, 4 perinatologists and 6 pediatric intensivists, as well as 17 other staff members (associate, clinical and administrative) to MEDNAX’s Pediatrix Medical Group division. All of the acquired practices are affiliated with Sutter Memorial Hospital and Sutter Roseville Medical Center.

CSMGS, as a group, has provided high quality care for patients in the Sacramento area since 1995 in hospital, clinical and office settings, with a dedicated commitment to the community. Its physicians and clinicians were pioneers of the Neonatal Advanced Life Support (NALS) program for transports that has since been emulated throughout California and other western states and were the first in Northern California to practice the extracorporeal membrane oxygenation (ECMO) technique in children. The annual NICU patient volume exceeds 22,000 patient days.

“We carefully evaluated our long term options for providing the highest quality care in light of the shifting healthcare environment, and made the decision to join a patient-focused group with a proven model of success,” said Andrew Wertz, M.D., President of CSMGS. “This partnership provides an opportunity for our physicians to continue to do what they do best - take care of our patients. We now have the opportunity to share best practices with more than 300 other neonatology intensive care units and have access to research, education and administrative support that will ultimately be a tremendous benefit to our Sacramento community.”

The physicians joining as a result of these transactions will now be part of MEDNAX’s Pediatrix Medical Group, a national medical group consisting of the nation’s leading neonatal, maternal-fetal medicine, pediatric cardiology, and other pediatric specialty physicians.

These practices were acquired for cash and the transactions are expected to be immediately accretive to its earnings. No additional terms of the transactions were disclosed.

With these acquisitions, three physician group practices have become part of Pediatrix Medical Group in 2012.


MEDNAX, Inc., is a national medical group that comprises the nation's leading provider of neonatal, maternal-fetal and pediatric physician subspecialty services as well as anesthesia services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives and clinical research to enhance patient outcomes and provide high-quality, cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was founded in 1979 and now includes neonatal physicians who provide services at more than 300 neonatal intensive care units, who collaborate with affiliated maternal-fetal medicine, pediatric cardiology and pediatric critical care physician subspecialists to provide a clinical care continuum. Pediatrix is also the nation's largest provider of newborn hearing screens. In 2007, the Company expanded into anesthesia services. Today, American Anesthesiology includes more than 900 anesthesiologists and advanced practitioners. MEDNAX, through its affiliated professional corporations, employs more than 1,800 physicians in 34 states and Puerto Rico. Additional information is available at

Certain statements and information in this press release may be deemed to contain forward-looking statements which may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as "believe", "hope", "may", "anticipate", "should", "intend", "plan", "will", "expect", "estimate", "project", "positioned", "strategy" and similar expressions, and are based on assumptions and assessments made by MEDNAX's management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in MEDNAX's most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled "Risk Factors", as well MEDNAX's current reports on Form 8-K,filed with the Securities and Exchange Commission.

Source: MEDNAX, Inc.

David Parker, 954-384-0175, x-5300
Vice President, Corporate Communications & Investor Relations